Information  X 
Enter a valid email address

Omega Diagnostics Ord 4P (ODX)

Related News

29-Aug-2017 02:31 PM

All resolutions passed at AGM of Omega Diagnostics

Omega Diagnostics Group has confirmed that all resolutions were passed by shareholders at today's Annual General Meeting. At 2:31pm: (LON:ODX) Omega Diagnostics Group PLC share price was -0.13p at 22.5p Story provided by StockMarketWire.com...
17-Jul-2017 02:24 PM

Omega updates on Open Offer

Omega Diagnostics Group has confirmed that it has received valid applications under the recently announced Open Offer of 3,854,844 shares from qualifying shareholders. It said this represents approximately 67.4% of the Open Offer shares. Qualifying shar
06-Jul-2017 01:26 PM

Omega updates on sale and leaseback agreement

Omega Diagnostics Group said it has concluded the sale and leaseback of the building owned by its wholly owned subsidiary, Omega Diagnostics GmbH, and will receive gross proceeds of €800,000. The Company added that it has simultaneously entered into
30-Jun-2017 04:20 PM

Broker Forecast - finnCap issues a broker note on Omega Diagnostics Group PLC

finnCap today reaffirms its corporate investment rating on Omega Diagnostics Group PLC (LON:ODX) and raised its price target to 30p (from 28p). Story provided by StockMarketWire.com...
30-Jun-2017 01:25 PM

Omega successfully raises £2.6m

Omega Diagnostics has announced that the Company has raised a total of £2.6m (before expenses) with new and existing investors of 13,116,881 Placing Shares and 1,166,666 Subscription Shares at a price of 18p per share. At 1:25pm: (LON:ODX) Omega
25-Apr-2017 07:45 AM

Omega Diagnostics sees FY adj. pretax profit at £1.1m

Omega Diagnostics says its FY results will be in line with market views, with revenues seen at £14.3m and adjusted profit before tax at £1.1m. "We have reached a significant milestone in achieving design freeze with our VISITECT CD4 deve
21-Nov-2016 07:32 AM

Omega Diagnostics improves H1 pretax profit

Omega Diagnostics has improved its H1 pretax profit to £305,447, from £177,360. Revenue was £6.8m, from £6.1m. Chair David Evans commented: "We have made good progress on our key Visitect CD4 development project and we have
27-Jun-2016 07:40 AM

Omega pre-tax profit down to £1.35m

Medical diagnostics firm Omega (ODX) said its full year pre-tax profit dropped from £1.37 million to £1.35 million. Omega is one of the UK's leading companies in the fast growing area of food intolerance, operating in markets supplying t
21-Apr-2016 07:47 AM

Omega Diagnostics sees FY results in line with views

Omega Diagnostics said its FY results will be in line with market expectations. Revenues for the year are seen at GBP12.7m and adjusted profit before tax will be in the range of GBP1.2m to GBP1.3m. Revenue of GBP12.7m would be 6% ahead of last year in co
30-Nov-2015 07:41 AM

Omega Diagnostics' H1 pretax profit slips

Omega Diagnostics has posted an H1 pretax profit of GBP177,360, from a profit of GBP208,418. Revenue was GBP6.1m, from GBP5.7m. The performance was in line with management's expectations, the company said. Story provided by StockMarketWire.co
15-Apr-2015 07:39 AM

Omega Diagnostics sees FY results in line

Omega Diagnostics said results for the year to 31 March 2015 will be in line with market expectations. Revenues for the year are expected to be £12.1m and adjusted profit before tax (before acquisition costs, share based payments, IFRS-related discount
26-Nov-2014 07:55 AM

Omega Diagnostics improves H1 pretax profit

Omega Diagnostics has improved its H1 pretax profit to £0.21m, from a year-ago profit of £0.16m. Revenue was £5.7m, from £5.6m. It remains frustrated by 'inevitable' delays related to Visitect CD4. Chairman David Evans commented on Omega&a
24-Oct-2014 07:50 AM

ODX warns

Omega Diagnostics said due to careful management of costs and an improved segmental mix of business its underlying pretax profit is expected to be about £0.56m, some 30% up on the year. It defined underlying pretax profit as before acquisition costs, sh
28-Aug-2014 01:14 PM

Omega resolutions passed at AGM

Omega Diagnostics Group has confirmed that all resolutions proposed at its annual general meeting earlier today were passed. At 1:14pm: (LON:ODX) Omega Diagnostics Group PLC share price was +0.63p at 20.75p Story provided by StockMarketWire.com...
23-Jun-2014 07:56 AM

Omega Diagnostics almost doubles FY pretax profit

Omega Diagnostics almost doubled its FY pretax profit to £0.54m, from a profit of £0.28m. Revenue was £11.6m, from £11.3m. "Our future landscape is brightened, as well as dominated, by the prospects for our Visitect CD4 test, which is now well i
25-Feb-2014 10:23 AM

Omega Diagnostics secures African patent

Omega Diagnostics Group,(AIM: ODX), the medical diagnostics company focused on allergy, food intolerance and infectious disease, has just been informed by the Burnet Institute that its exclusively licensed CD4 test for monitoring HIV-positive patients has
27-Nov-2013 07:51 AM

Omega Diagnostics H1 pretax profit rises

Omega Diagnostics posted an H1 pretax profit of £0.16m, from £0.13m. Revenue was £5.6m, from £5.5m. It said H1 trading was in line with management's expectations. "The core business has held up as certain headwinds have been mitigated with
17-Oct-2013 07:57 AM

Omega Diagnostics sees H1 pretax profit up

Omega Diagnostics said first-half turnover is expected to be £5.59m, slightly ahead of last year's £5.53m. Underlying pretax profit is expected to be at least 10% ahead of the £0.38m earned in the previous half-year period. "The Company ha
28-Aug-2013 04:15 PM

Omega resolutions passed at AGM

Omega Diagnostics has confirmed that all resolutions proposed at its annual general meeting earlier today (28 August) were passed. At 4:15pm: (LON:ODX) share price was -0.37p at 15.13p Story provided by StockMarketWire.com...
01-Jul-2013 07:16 AM

Weakness in UK and Europe hits Omega

Medical diagnostics company Omega said turnover was up 1% to £11.3m in the year to end-March (2012: £11.1m). Gross profit rose 1% to £7.1m (2012: £7m). Adjusted profit before tax was down by 22% to £0.78m (2012: £1.00m). Adjusted EPS 1.3p (2012: 1
10-Apr-2013 07:47 AM

Omega Diagnostics sees underlying FY profit at £0.8m

Omega Diagnostics said it sees its full-year underlying pretax profit at about £0.8 million, while it expects revenue for the same period to come in at £11.26 million. The pretax profit figure excluded acquisition costs, share based payments, IFRS-rela
21-Nov-2012 08:55 AM

Omega shows revenue and gross profit in line with last year

Omega reports that revenue for the half year to end of September remained constant compared to the prior period at £5.53m (2011: £5.53m). A reduction in revenue in Germany, mainly as a result of a weaker euro compared to the prior year has, in part,
02-Jul-2012 07:33 AM

Omega slashes debt

Diagnostics company Omega said turnover rose 41% to £11.1m in the year to end-March (2011: £7.9m); gross profit rose 49% to £7m (2011: £4.7m). Allergy and autoimmune revenue was up 191% to £4.48m (2011: £1.54m). Food Intolerance revenue rose 10%
19-Jun-2012 09:56 AM

Omega Diagnostics works with Australian organisation

Omega Diagnostics, the medical diagnostics company that concentrates on allergy, food intolerance and infectious disease, is working closely with the Burnet Institute in Melbourne, Australia. It has announced that, subsequent to entering into agreements
16-Apr-2012 09:19 AM

Omega expects improved numbers for year

Omega, the medical diagnostics company, announces that revenue for the year ended 31 March 2012 is expected to be £11.12m, approximately 41% ahead of last year's result (31 March 2011: £7.90m). On a like-for-like basis, excluding the contribution

a d v e r t i s e m e n t